Mrv0541 02231218072D 15 16 0 0 1 0 999 V2000 3.7445 -0.4772 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.8472 2.2848 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.5146 0.9748 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.4347 0.1902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1796 0.9748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2597 0.1902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4347 -0.6348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 -0.0647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8472 1.4598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1491 -1.0473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7201 -1.0473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2992 1.2298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1491 -1.8723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7201 -1.8723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4347 -2.2848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 6 2 0 0 0 0 2 9 2 0 0 0 0 3 6 1 0 0 0 0 3 9 1 0 0 0 0 3 12 1 0 0 0 0 4 5 1 0 0 0 0 4 6 1 0 0 0 0 4 7 1 0 0 0 0 4 8 1 0 0 0 0 5 9 1 0 0 0 0 7 10 2 0 0 0 0 7 11 1 0 0 0 0 10 13 1 0 0 0 0 11 14 2 0 0 0 0 13 15 2 0 0 0 0 14 15 1 0 0 0 0 M END > DB05246 > drugbank > CN1C(=O)CC(C)(C1=O)C1=CC=CC=C1 > InChI=1S/C12H13NO2/c1-12(9-6-4-3-5-7-9)8-10(14)13(2)11(12)15/h3-7H,8H2,1-2H3 > AJXPJJZHWIXJCJ-UHFFFAOYSA-N > C12H13NO2 > 203.2371 > 203.094628665 > 2 > 28 > -9.395707543759153e-13 > 21.44928603056838 > 1 > 0 > 0 > 1 > 1,3-dimethyl-3-phenylpyrrolidine-2,5-dione > 1.46 > 1.4630090576666663 > -1.98 > 0 > 0 > 2 > 0 > 19.0270705097855 > -7.236744369121766 > 37.38 > 56.348600000000005 > 1 > 1 > 2.13e+00 g/l > tetrahydrofolic acid > 1 > DB05246 > approved > Methsuximide > (RS)-1,3-Dimethyl-3-phenyl-2,5-pyrrolidindion; 1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine; 1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione; 1,3-Dimethyl-3-phenylsuccinimide; alpha-Methyl-alpha-phenyl N-methyl succinimide; alpha-Methylphensuximide; Mesuximida; Mesuximide; Mesuximidum; Methsuximid; Methsuximide; Metosuccimmide; N-methyl-alpha-methyl-alpha-phenylsuccinimide; N,2-Dimethyl-2-phenylsuccinimide > Celontin; Celontin Cap 300mg; Methsuximide > Petinutin $$$$